Dexcom signals beyond the news: 40+ signals from 5 sources
The latest Dexcom signal on this page is from Sep 29, 2026 (Patents): "DEXCOM, INC.'s patent output is slowing: 71 grants in the past year, 4 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (13) and Patents (10).
Public (DXCM)Medical Equipment Manufacturing10,000+ employeesdexcom.comLinkedIn
- Signals
- 40+
- Sources
- 5
- Last 90 days
- 25
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Dexcom signals by source
40+ signals for Dexcom across 5 sources.
Patents · Patent pace
DEXCOM, INC.'s patent output is slowing: 71 grants in the past year, 4 in the past 30 days.
Over the past year DEXCOM, INC. received 71 US patent grants, concentrated in health tech / medical informatics and signal transmission; the recent pace (14 in 90 days) is slowing versus its trailing baseline.
- Grants, 12 months
- 71
- Grants, 90 days
- 14
- Grants, 30 days
- 4
- Pace
- Decelerating
Patents · Patent grant
Dexcom was granted a patent for enhanced glucose-monitoring support.
In September 2026 Dexcom patented tools for sharing glucose data and providing social support through connected health-management systems.
- Patent title
- Continuous glucose monitoring follower and social support enhancements
- Grant date
- Sep 29, 2026
- Inventors
- Carly Rose Olson, Afshan A. Kleinhanzl, Adam G. Noar, Harry Shaw Strothers
- Tech area
- health tech / medical informatics
Patents · Patent grant
Dexcom was granted a patent for visualizing pregnancy-related glucose data.
In September 2026 Dexcom patented tools for tracking and presenting pregnancy-related analyte readings, helping clinicians and patients review trends through a digital health interface.
- Patent title
- Tracking, reporting, and visualizing pregnancy-related analyte data
- Grant date
- Sep 15, 2026
- Inventors
- Charles R. Stroyeck, Sonya Frangopoulos, Douglas S. Kanter, Afshan Kleinhanzl
Glassdoor · Growth opportunities
Employees report learning and growth opportunities despite busy environment
One HR Business Advisor states the busy environment fosters learning and growth, while a Software Test Development Engineer II also notes great opportunities for learning and growth.
- Overall rating
- 3.6 of 5
- CEO approval
- 84%
- Reviews read
- 4
- Review window
- Aug 13, 2026 to Aug 25, 2026
Glassdoor · Strategic direction unclear
Employees report slow execution of company vision despite clear direction
A reviewer noted that while the company direction is clear, it is quite slow to turn into vision.
- Overall rating
- 3.6 of 5
- CEO approval
- 84%
- Reviews read
- 4
- Review window
- Aug 13, 2026 to Aug 25, 2026
Glassdoor · Cross functional collaboration issues
Software engineer mentions weak organizational structure impacting operations
A Software Test Development Engineer II mentions the organizational structure is not as strong as desired.
- Overall rating
- 3.6 of 5
- CEO approval
- 84%
- Reviews read
- 4
- Review window
- Aug 13, 2026 to Aug 25, 2026
Website changes · Product launch
Dexcom clarified that Dexcom G7 insulin pumps are available for Pharmac funding users who are not connected to a pump, with predictive alert functions.
The FAQ changed from G6/G7 eligibility to G7 eligibility and now states that G7 users may benefit from predictive alert functions while choosing not to connect to a funded insulin pump.
- Page
- /en-nz/pharmacfunding
Website changes · Product update
Dexcom updated the email addresses for multiple customer-service and support contacts on the NZ pharmac funding page.
The diff replaces the email-protection links for the NZMS Diabetes representative, customer service, pharmacy ordering, and general support contacts.
- Page
- /en-nz/pharmacfunding
Web traffic · Sustained growth
dexcom.com shows sustained growth with 3 consecutive months of increases, up 22% overall to 3M.
- Monthly visits
- 2,761,381
- Month over month
- +6.1%
- 3-month change
- +22%
- Global rank
- 18,441
LinkedIn
New year, new era of transformation.
New year, new era of transformation. We’re kicking off the year at #CES2026 with big conversations about the future of health. On January 7, our new CEO Jake Leach will join industry leaders to explore how continuous health monitoring, like biosensing technology, is helping people form healthy habits and manage and...
- Likes
- 119
- Comments
- 3
- Tags
- Executive Moves, Healthcare Technology, Healthcare Operations
Showing 10 of 40+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Dexcom with the Signal API
One POST /v1/companies/enrich call with dexcom.com returns Dexcom signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "dexcom.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Dexcom other signals
What signals does Autobound track for Dexcom besides news and filings?
What do employees say about working at Dexcom?
Has Dexcom been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .